Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.

Livney MG, Clark CM, Karlawish JH, Cartmell S, Negrón M, Nuñez J, Xie SX, Entenza-Cabrera F, Vega IE, Arnold SE.

Am J Geriatr Psychiatry. 2011 May;19(5):430-9. doi: 10.1097/JGP.0b013e3181f7d881.

2.

The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease.

Harwood DG, Kalechstein A, Barker WW, Strauman S, St George-Hyslop P, Iglesias C, Loewenstein D, Duara R.

Int J Geriatr Psychiatry. 2010 May;25(5):511-8. doi: 10.1002/gps.2372.

PMID:
19750560
3.

Alzheimer's disease symptom severity in blacks and whites.

Shadlen MF, Larson EB, Gibbons L, McCormick WC, Teri L.

J Am Geriatr Soc. 1999 Apr;47(4):482-6.

PMID:
10203126
4.

Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.

Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.

Arch Neurol. 2006 Nov;63(11):1586-90.

PMID:
17101827
5.

Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population.

Stewart R, Russ C, Richards M, Brayne C, Lovestone S, Mann A.

Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):251-6.

PMID:
11351136
6.

Rates of dementia in three ethnoracial groups.

Gurland BJ, Wilder DE, Lantigua R, Stern Y, Chen J, Killeffer EH, Mayeux R.

Int J Geriatr Psychiatry. 1999 Jun;14(6):481-93.

PMID:
10398359
7.

Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.

Mauri M, Sinforiani E, Bono G, Cittadella R, Quattrone A, Boller F, Nappi G.

Funct Neurol. 2006 Oct-Dec;21(4):223-8.

PMID:
17367583
8.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
9.

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R.

Arch Gen Psychiatry. 1996 Feb;53(2):175-82.

PMID:
8629893
10.

Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R.

Am J Hum Genet. 1996 Mar;58(3):574-84.

11.

Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals.

Clark CM, DeCarli C, Mungas D, Chui HI, Higdon R, Nuñez J, Fernandez H, Negrón M, Manly J, Ferris S, Perez A, Torres M, Ewbank D, Glosser G, van Belle G.

Arch Neurol. 2005 May;62(5):774-8.

PMID:
15883265
12.

Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.

O'Bryant SE, Johnson L, Balldin V, Edwards M, Barber R, Williams B, Devous M, Cushings B, Knebl J, Hall J.

J Alzheimers Dis. 2013;33(2):373-9. doi: 10.3233/JAD-2012-121420.

13.

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.

Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.

Dement Geriatr Cogn Disord. 2006;22(1):73-82. Epub 2006 May 12.

PMID:
16699282
14.

Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample.

Harwood DG, Barker WW, Ownby RL, Mullan M, Duara R.

Alzheimer Dis Assoc Disord. 2002 Jan-Mar;16(1):8-14.

PMID:
11882744
15.

Apolipoprotein-E epsilon 4 allele frequency and conferred risk for Cuban Americans with Alzheimer's disease.

Sevush S, Peruyera G, Crawford F, Mullan M.

Am J Geriatr Psychiatry. 2000 Summer;8(3):254-6.

PMID:
10910426
16.

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.

Lasser RA, Dukoff R, Levy J, Levin R, Lehtimäki T, Seubert P, Sunderland T.

Int J Geriatr Psychiatry. 1998 Nov;13(11):767-74.

PMID:
9850873
17.

Relationship of age, education, and occupation with dementia among a community-based sample of African Americans.

Callahan CM, Hall KS, Hui SL, Musick BS, Unverzagt FW, Hendrie HC.

Arch Neurol. 1996 Feb;53(2):134-40.

PMID:
8639062
18.

Evaluation of choline acetyltransferase gene polymorphism (2384 G/A) in Alzheimer's disease and mild cognitive impairment.

Tang M, Rao D, Ma C, Guo Y, Han H, Ling K, Ling Y.

Dement Geriatr Cogn Disord. 2008;26(1):9-14. doi: 10.1159/000140612. Epub 2008 Jun 19.

PMID:
18562794
19.

Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001.

Hall KS, Gao S, Baiyewu O, Lane KA, Gureje O, Shen J, Ogunniyi A, Murrell JR, Unverzagt FW, Dickens J, Smith-Gamble V, Hendrie HC.

Alzheimers Dement. 2009 May;5(3):227-33. doi: 10.1016/j.jalz.2009.01.026.

20.

Quality, and not just quantity, of education accounts for differences in psychometric performance between african americans and white non-hispanics with Alzheimer's disease.

Chin AL, Negash S, Xie S, Arnold SE, Hamilton R.

J Int Neuropsychol Soc. 2012 Mar;18(2):277-85. doi: 10.1017/S1355617711001688. Epub 2012 Feb 3.

Items per page

Supplemental Content

Write to the Help Desk